-
Sector Analysis
Automotive Tyres and Wheels Market Trends, Sector Overview and Forecast to 2028
Automotive Tyres and Wheels Market Report Overview The tyres and wheels market size was 942.7 million units in 2023. The market will grow at a CAGR of more than 1% during 2023-2028. The rising number of EV adoption is driving the demand for specialized tyres while the increasing income of the middle class is significantly boosting passenger car sales. In 2023, Asia-Pacific accounted for a significant share of the automotive tyres and wheels market. Automotive Tyres and Wheels Market Outlook,...
-
Sector Analysis
Automotive Active and Passive Safety Systems Market Trends, Sector Overview and Forecast to 2028
Automotive Active and Passive Safety Systems Market Report Overview The automotive active and passive safety systems market size was 894.5 million units in 2023. The market will grow at a CAGR of more than 3% during 2023-2028. Since driving distractions from phones, music, and infotainment are becoming more commonplace, automakers are researching and developing advanced safety and driver assistance systems to protect the passengers inside the vehicle from collisions. In 2023, Asia-Pacific accounted for a significant share of the automotive...
-
Sector Analysis
Automotive Transmission and Clutch Technologies Market Trends, Sector Overview and Forecast to 2028
Automotive Transmission and Clutch Technologies Market Overview The transmission and clutch technologies market size was 175.8 million units in 2023. The market will grow at a CAGR of more than 2% during 2023-2028. The market growth is primarily attributed to the stringent fuel efficiency and emission regulations worldwide that are prompting manufacturers to focus on fuel-efficient transmission systems. In 2023, Asia-Pacific accounted for a significant share of the automotive transmission and clutch technologies market. Automotive Transmission and Clutch Technologies Market...
-
Sector Analysis
Automotive Vision Systems Market Trends, Sector Overview and Forecast to 2028
Automotive Vision Systems Market Report Overview The automotive vision systems market size was estimated at 709.3 million units in 2023. The market will grow at a CAGR of more than 1% during 2023-2028. Increased consumer awareness regarding road safety and a desire for advanced features are driving the growth of vision system technologies. The Asia-Pacific region had a significant share in the automotive vision systems market. Automotive Vision Systems Market Outlook 2023-2028 (Million Units) Buy the Full Report for Additional...
-
Sector Analysis
Automotive Engine Technologies Market Trends, Sector Overview and Forecast to 2028
Automotive Engine Technologies Market Report Overview The automotive engine technologies market size was estimated at 440.9 million units in 2023. The engine technologies market will register a negative CAGR of more than 1% during 2023-2028. The Asia-Pacific region led the global engine technologies market in 2023. Automotive Engine Technologies Market Outlook 2023-2028 (Million Units) Buy The Full Report for Additional Automotive Engine Technologies Market Forecast Insights or Download the Free Sample Report The automotive engine technologies market report provides a...
-
Sector Analysis
Automotive Braking Systems Market Trends, Sector Overview and Forecast to 2028
Automotive Braking Systems Market Report Overview The automotive braking systems market size was 578.5 million units in 2023. The market will grow at a CAGR of more than during 2023-2028. Rapid growth in EV adoption is driving the demand for regenerative braking systems. In 2023, Asia-Pacific accounted for a significant share of the automotive braking systems market. Automotive Braking Systems Market Outlook, 2023-2028 (Million Units) Buy the Full Report for More Insights on the Automotive Braking Systems Market Report Forecast...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Daratumumab in Chronic Lymphocytic Leukemia (CLL)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Daratumumab in Chronic Lymphocytic Leukemia (CLL) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Daratumumab in Chronic Lymphocytic Leukemia (CLL) Drug Details: Daratumumab...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Daratumumab in Lymphoblastic Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Daratumumab in Lymphoblastic Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Daratumumab in Lymphoblastic Lymphoma Drug Details: Daratumumab ((HuMax-CD38, JNJ-54767414, Darzalex, Dalinvi, Darzalex...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Daratumumab in Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Daratumumab in Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Daratumumab in Acute Lymphocytic Leukemia (ALL,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Daratumumab in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Daratumumab in Pancreatic Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Daratumumab in Pancreatic Cancer Drug Details: Daratumumab ((HuMax-CD38, JNJ-54767414, Darzalex, Dalinvi, Darzalex...